Turn Bio adds veteran executives with decades of international business development, intellectual property expertise

MOUNTAIN VIEW, Calif., March 7, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure now-untreatable, chronic, age-related conditions, today announced the addition of global expertise in partnership development and intellectual...

Click to view original post